Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Infections by Candida and cryptococci]

J Berenguer1, R Blázquez, I Ocaña

  • 1Hospital Gregorio Marañón, Madrid. juaberber@redestb.es

Enfermedades Infecciosas Y Microbiologia Clinica
|December 22, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improving long-term monitoring in NMIBC: Digital Uromonitor® (dUM) as a complementary tool to cystoscopy for two-year recurrence risk stratification.

Actas urologicas espanolas·2026
Same author

State of art of robotic prostatectomy: the way we do it in Catalonia, Spain.

Actas urologicas espanolas·2024
Same author

Evaluating the impact of the learning curve on the perioperative outcomes of robot-assisted radical cystectomy with intracorporeal urinary diversion.

Actas urologicas espanolas·2021
Same author

Evaluating the impact of the learning curve on the perioperative outcomes of robot-assisted radical cystectomy with intracorporeal urinary diversion.

Actas urologicas espanolas·2021
Same author

Current status of genetic urinary biomarkers for surveillance of non-muscle invasive bladder cancer: a systematic review.

BMC urology·2020
Same author

Extracellular NK histones promote immune cell anti-tumor activity by inducing cell clusters through binding to CD138 receptor.

Journal for immunotherapy of cancer·2019
Same journal

New COVID-19 vaccination recommendations in Spain: Optimizing for next seasons.

Enfermedades infecciosas y microbiologia clinica·2025
Same journal

[Description of 12 HIV-positive patients who have had the COVID-19 in our area].

Enfermedades infecciosas y microbiologia clinica·2024
Same journal

[SARS-CoV-2 infection as trigger multisystem inflammatory syndrome?]

Enfermedades infecciosas y microbiologia clinica·2024
Same journal

Impact of COVID-19 on Madrid hospital system.

Enfermedades infecciosas y microbiologia clinica·2024
Same journal

[COVID-19 and influenza A coinfection: a matter of principle].

Enfermedades infecciosas y microbiologia clinica·2024
Same journal

COVID and CARE®. Mobile application for monitoring SARS-CoV-2 positive patients after hospitalization.

Enfermedades infecciosas y microbiologia clinica·2024
See all related articles

Highly active antiretroviral therapy (HAART) has decreased fungal infections in AIDS patients. Refractory candidiasis and cryptococcosis require specific antifungal treatments, with HAART as the preferred therapy for resistant cases.

Area of Science:

  • Infectious Diseases
  • HIV/AIDS Management
  • Mycology

Context:

  • Highly active antiretroviral therapy (HAART) has significantly reduced opportunistic fungal infections like candidiasis and cryptococcosis in individuals with Acquired Immunodeficiency Syndrome (AIDS).
  • Fluconazole is the primary antifungal agent for candidiasis, with treatment durations varying by infection site.
  • Resistant fungal infections are increasingly observed in advanced HIV disease, particularly in patients with prior fluconazole exposure.

Purpose:

  • To outline current therapeutic strategies for fungal infections in AIDS patients.
  • To detail the role of HAART in managing and preventing opportunistic mycoses.
  • To describe treatment protocols for candidiasis and cryptococcal meningitis, including management of refractory cases and complications.

Summary:

Related Experiment Videos

  • HAART has dramatically decreased the incidence of mucosal candidiasis and cryptococcosis in AIDS patients.
  • Fluconazole is the preferred treatment for candidiasis, while cryptococcal meningitis requires induction with amphotericin B and flucytosine, followed by fluconazole.
  • Refractory fungal infections necessitate HAART, and management of cryptococcal meningitis may involve serial lumbar punctures or CSF drains for elevated intracranial pressure.

Impact:

  • Provides essential guidance for clinicians managing fungal infections in the context of HIV/AIDS.
  • Highlights the critical role of HAART in controlling opportunistic infections.
  • Offers specific treatment regimens for both common and refractory fungal infections, improving patient outcomes.